- GlobeNewswire•7 hours agoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Regulus Therapeutics Inc. (RGLS) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
STEVENSON, Md., Feb. 26, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...
- Accesswire•2 days agoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Regulus Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
IRVINE, CA / ACCESSWIRE / February 24, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Regulus Therapeutics Inc. ("Regulus" or the "Company") ...
- Accesswire•2 days agoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Regulus Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - RGLS
NEW YORK, NY / ACCESSWIRE / February 24, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Regulus Therapeutics Inc. ("Regulus" or the "Company") (NASDAQ: ...
RGLS : Summary for Regulus Therapeutics Inc. - Yahoo Finance
Regulus Therapeutics Inc. (RGLS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.00 x 3000|
|Ask||1.35 x 600|
|Day's Range||0.94 - 1.10|
|52 Week Range||0.94 - 8.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.84|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|